Literature DB >> 10527838

Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide.

J Luo1, Z Luo, N Zhou, J W Hall, Z Huang.   

Abstract

The N-terminus of stromal cell-derived factor 1 (SDF-1) is known to be a critical site for CXCR4 receptor binding and signaling. However, the functional role of other regions, in particular the C-terminal helix of SDF-1, has yet to be defined. In this study, we designed and synthesized a peptide model of SDF-1 containing its N- and C-terminal regions. The attachment of the C-terminus of SDF-1, which by itself had no activity in receptor binding and signaling, dramatically increased the effect of the N-terminal fragment in inducing chemotaxis and intracellular Ca(2+) influx in sup T1 cells compared with the peptide containing only the N-terminal sequence. The enhancement in activity was not due to the increase in receptor affinity as the N,C-terminal peptide did not show higher CXCR4 binding than the N-terminal peptide. On the other hand, the intracellular Ca(2+) influx activated by the N,C-terminal peptide, but not the N-terminal peptide, was completely abolished by the addition of heparin, suggesting that the C-terminal fragment of the peptide binds glycosaminoglycans (GAGs) and exerts an effect to modulate biological activity. These data raise the possibility that the C-terminus in native SDF-1 is one of interaction sites with GAGs and may be associated with biological function of SDF-1. Furthermore, this study demonstrates an approach for the design of novel agonists or antagonists of other chemokine receptors that possess enhanced biological activity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527838     DOI: 10.1006/bbrc.1999.1476

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

Review 2.  Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.

Authors:  Won-Tak Choi; Yilei Yang; Yan Xu; Jing An
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

3.  Bi-ligand surfaces with oriented and patterned protein for real-time tracking of cell migration.

Authors:  Varadraj N Vernekar; Charles S Wallace; Mina Wu; Joshua T Chao; Shannon K O'Connor; Aimee Raleigh; Xiaji Liu; Jason M Haugh; William M Reichert
Journal:  Colloids Surf B Biointerfaces       Date:  2014-09-19       Impact factor: 5.268

Review 4.  Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.

Authors:  Won-Tak Choi; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

5.  Stromal-derived factor-1 alpha-loaded PLGA microspheres for stem cell recruitment.

Authors:  Daisy P Cross; Chun Wang
Journal:  Pharm Res       Date:  2011-05-26       Impact factor: 4.200

6.  Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.

Authors:  William Hiesinger; Jose Manuel Perez-Aguilar; Pavan Atluri; Nicole A Marotta; John R Frederick; J Raymond Fitzpatrick; Ryan C McCormick; Jeffrey R Muenzer; Elaine C Yang; Rebecca D Levit; Li-Jun Yuan; John W Macarthur; Jeffery G Saven; Y Joseph Woo
Journal:  Circulation       Date:  2011-09-13       Impact factor: 29.690

7.  Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.

Authors:  William Hiesinger; John R Frederick; Pavan Atluri; Ryan C McCormick; Nicole Marotta; Jeffrey R Muenzer; Y Joseph Woo
Journal:  J Thorac Cardiovasc Surg       Date:  2010-11       Impact factor: 5.209

8.  Endogenous Peptide Inhibitors of HIV Entry.

Authors:  Mirja Harms; Manuel Hayn; Fabian Zech; Frank Kirchhoff; Jan Münch
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 9.  Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Authors:  William Hiesinger; Andrew B Goldstone; Y Joseph Woo
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

Review 10.  Chemokine oligomerization in cell signaling and migration.

Authors:  Xu Wang; Joshua S Sharp; Tracy M Handel; James H Prestegard
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.